We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Huntsman (HUN) to Acquire CVC Thermoset Specialties for $300M
Read MoreHide Full Article
Huntsman Corporation (HUN - Free Report) announced a deal to acquire CVC Thermoset Specialties, a North American specialty chemical producer that serves the industrial composites, adhesives and coatings markets.
CVC Thermoset Specialties is part of Emerald Performance Materials LLC and has annual revenues of roughly $115 million, with two production facilities located in Akron, OH, and Maple Shade, NJ.
Per the terms of the deal, Huntsman is expected to pay $300 million in the all-cash transaction financed from available liquidity, subject to customary closing adjustments.
The purchase price reflects an adjusted EBITDA multiple of around 10 times or between roughly 7-8 times pro forma for synergies based on 2019. Notably, the transaction is slated to close in the middle of 2020.
Per Huntsman, the CVC Thermoset Specialties acquisition adds an important complementary technology breadth to its portfolio of Advanced Materials and the latter’s unique products can make systems, using Huntsman’s class-leading epoxy-based material, even tougher, stronger, and more robust. The buyout will also improve Huntsman’s ability to generate differentiation in customers' applications, especially through its strong formulation business. Notably, Huntsman anticipates generating substantial synergies within two years.
The company's shares have lost 32.5% in the past year compared with the industry’s 46.5% decline.
On the fourth-quarter earnings call, Huntsman stated that it will remain focused on investing in its downstream and specialty platforms in 2020 through acquisitions and organically. It will also remain balanced in its capital allocation, including opportunistic share repurchases and maintaining a competitive dividend payout.
For the Polyurethanes unit, the company expects demand headwinds in several major markets and regions in 2020. It also anticipates differentiated MDI (methylene diphenyl diisocyanate) margins to be stable.
For Performance Products, Huntsman sees growth in performance amines. It also expects weak maleic anhydride demand, with stable margins.
For Advanced Materials, the company expects stable overall margins amid
weakness in industrial markets and demand headwind in aerospace.
For the Textile Effects unit, Huntsman expects growth in specialty products. It also expects stable volumes and improved margins.
The company currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Franco-Nevada Corporation (FNV - Free Report) , Barrick Gold Corporation (GOLD - Free Report) and NovaGold Resources Inc. (NG - Free Report) .
Franco-Nevada has a projected earnings growth rate of 24.2% for 2020. The company’s shares have rallied 40% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Barrick Gold currently has a Zacks Rank #2 (Buy) and a projected earnings growth rate of 43.1% for 2020. The company’s shares have rallied 21% in a year.
NovaGold has a projected earnings growth rate of 11.1% for 2020. It currently carries a Zacks Rank #2. The company’s shares have gained 86% in a year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>Huntsman Corporation (HUN - Free Report) announced a deal to acquire CVC Thermoset Specialties, a North American specialty chemical producer that serves the industrial composites, adhesives and coatings markets.
CVC Thermoset Specialties is part of Emerald Performance Materials LLC and has annual revenues of roughly $115 million, with two production facilities located in Akron, OH, and Maple Shade, NJ.
Per the terms of the deal, Huntsman is expected to pay $300 million in the all-cash transaction financed from available liquidity, subject to customary closing adjustments.
The purchase price reflects an adjusted EBITDA multiple of around 10 times or between roughly 7-8 times pro forma for synergies based on 2019. Notably, the transaction is slated to close in the middle of 2020.
Per Huntsman, the CVC Thermoset Specialties acquisition adds an important complementary technology breadth to its portfolio of Advanced Materials and the latter’s unique products can make systems, using Huntsman’s class-leading epoxy-based material, even tougher, stronger, and more robust. The buyout will also improve Huntsman’s ability to generate differentiation in customers' applications, especially through its strong formulation business. Notably, Huntsman anticipates generating substantial synergies within two years.
The company's shares have lost 32.5% in the past year compared with the industry’s 52% decline.
On the fourth-quarter earnings call, Huntsman stated that it will remain focused on investing in its downstream and specialty platforms in 2020 through acquisitions and organically. It will also remain balanced in its capital allocation, including opportunistic share repurchases and maintaining a competitive dividend payout.
For the Polyurethanes unit, the company expects demand headwinds in several major markets and regions in 2020. It also anticipates differentiated MDI (methylene diphenyl diisocyanate) margins to be stable.
For Performance Products, Huntsman sees growth in performance amines. It also expects weak maleic anhydride demand, with stable margins.
For Advanced Materials, the company expects stable overall margins amid weakness in industrial markets and demand headwind in aerospace.
For the Textile Effects unit, Huntsman expects growth in specialty products. It also expects stable volumes and improved margins.
Zacks Rank & Stocks to Consider
The company currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the basic materials space are Franco-Nevada Corporation (FNV - Free Report) , Barrick Gold Corporation (GOLD - Free Report) and NovaGold Resources Inc. (NG - Free Report) .
Franco-Nevada has a projected earnings growth rate of 24.2% for 2020. The company’s shares have rallied 40% in a year. It currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Barrick Gold currently has a Zacks Rank #2 (Buy) and a projected earnings growth rate of 43.1% for 2020. The company’s shares have rallied 21% in a year.
NovaGold has a projected earnings growth rate of 11.1% for 2020. It currently carries a Zacks Rank #2. The company’s shares have gained 86% in a year.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Huntsman (HUN) to Acquire CVC Thermoset Specialties for $300M
Huntsman Corporation price-consensus-chart | Huntsman Corporation Quote